Drug Trial Radar · NCT03701581
4-aminopyridine Treatment for Nerve Injury
Last checked: Nov 20, 2026Latest source record: Dec 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
70
Planned (sponsor's estimate)
Start
Jun 5, 2021
Primary completion
Jul 2027
Study completion Dec 2028
Sponsor
- Lead sponsor
- John ElfarAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 10, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 45 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the role of 4-aminopyridine (4-AP) on the course of recovery after peripheral nerve traction and/or crush injury. This study aims to test the hypothesis that 4-aminopyridine speeds the often slow and unpredictable recovery after peripheral nerve traction and/or crush injuries.
Conditions
- Nerve Injury
- Prostate Cancer
Interventions
4-AminopyridineDrug
FDA-approved tablets.
PlaceboOther
Placebo will be tooled to look similar to the study drug.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Michigan Incontinence Sympton Index (M-ISI) (change over time)Time frame: Pre-operative visit, and every seven days (starting after surgery, i.e., 7 days post-op) for 6 months (up to 25 times).
- International Index of Erectile Function (IIEF) (change over time)Time frame: Pre-operative visit, and every seven days (starting after surgery, i.e., 7 days post-op) for 6 months (up to 25 times).
- Placebo vs. Active Drug QuestionnaireTime frame: through study completion, an average of 1 year
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
University of Arizona
Tucson, Arizona · Recruiting
University of Rochester
Rochester, New York · Terminated
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.